These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 12426205

  • 1. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH, Gebauer M, Güldenzoph B, Hecker M.
    Arterioscler Thromb Vasc Biol; 2002 Nov 01; 22(11):1784-9. PubMed ID: 12426205
    [Abstract] [Full Text] [Related]

  • 2. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F.
    Cardiovasc Res; 2003 Sep 01; 59(3):755-66. PubMed ID: 14499877
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P.
    Circulation; 2002 Dec 03; 106(23):2888-93. PubMed ID: 12460867
    [Abstract] [Full Text] [Related]

  • 4. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC, Ahmed Z, Mankoff R, Lidington EA, Ahmad S, Bhatia V, Kinderlerer A, Randi AM, Haskard DO.
    Circ Res; 2002 Oct 18; 91(8):696-703. PubMed ID: 12386146
    [Abstract] [Full Text] [Related]

  • 5. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells.
    Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, Ledet T.
    Biochem J; 2001 Dec 01; 360(Pt 2):363-70. PubMed ID: 11716764
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH, Schwabe O, Hecker M.
    Br J Pharmacol; 2002 May 01; 136(1):143-9. PubMed ID: 11976279
    [Abstract] [Full Text] [Related]

  • 7. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.
    Ortego M, Hernández AG, Bustos C, Blanco-Colio LM, Hernández-Presa MA, Tuñón J, Egido J.
    Eur J Pharmacol; 2002 Jul 19; 448(2-3):113-21. PubMed ID: 12144930
    [Abstract] [Full Text] [Related]

  • 8. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M.
    Arterioscler Thromb Vasc Biol; 2000 Jan 19; 20(1):61-9. PubMed ID: 10634801
    [Abstract] [Full Text] [Related]

  • 9. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
    Teupser D, Bruegel M, Stein O, Stein Y, Thiery J.
    Biochem Biophys Res Commun; 2001 Dec 14; 289(4):838-44. PubMed ID: 11735122
    [Abstract] [Full Text] [Related]

  • 10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J.
    Circulation; 2003 Sep 23; 108(12):1506-13. PubMed ID: 12952848
    [Abstract] [Full Text] [Related]

  • 11. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY, Fedtsov A, Madias NE.
    Hypertension; 2001 Nov 23; 38(5):1024-9. PubMed ID: 11711492
    [Abstract] [Full Text] [Related]

  • 12. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
    Takahashi HK, Mori S, Iwagaki H, Yoshino T, Tanaka N, Weitz-Schmidt G, Nishibori M.
    J Leukoc Biol; 2005 Mar 23; 77(3):400-7. PubMed ID: 15618295
    [Abstract] [Full Text] [Related]

  • 13. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
    Takahashi HK, Iwagaki H, Yagi T, Kanke T, Liu K, Yoshino T, Tanaka N, Nishibori M.
    Clin Immunol; 2007 Jun 23; 123(3):324-32. PubMed ID: 17482516
    [Abstract] [Full Text] [Related]

  • 14. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O, Dessy C, Desager JP, Balligand JL.
    Circulation; 2001 Jan 02; 103(1):113-8. PubMed ID: 11136695
    [Abstract] [Full Text] [Related]

  • 15. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G.
    Atherosclerosis; 2000 Oct 02; 152(2):359-66. PubMed ID: 10998463
    [Abstract] [Full Text] [Related]

  • 16. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F.
    Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):58-63. PubMed ID: 12524225
    [Abstract] [Full Text] [Related]

  • 17. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
    Stach K, Nguyen XD, Lang S, Elmas E, Weiss C, Borggrefe M, Fischer J, Kälsch T.
    Cardiol J; 2012 Jan 01; 19(1):20-8. PubMed ID: 22298164
    [Abstract] [Full Text] [Related]

  • 18. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
    Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC.
    J Thromb Haemost; 2007 Dec 01; 5(12):2537-46. PubMed ID: 17927807
    [Abstract] [Full Text] [Related]

  • 19. Statins have biphasic effects on angiogenesis.
    Weis M, Heeschen C, Glassford AJ, Cooke JP.
    Circulation; 2002 Feb 12; 105(6):739-45. PubMed ID: 11839631
    [Abstract] [Full Text] [Related]

  • 20. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
    Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H.
    Br J Pharmacol; 2007 Feb 12; 150(4):470-9. PubMed ID: 17220911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.